Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBay Pharmaceuticals (NBY) Goodwill (2021 - 2023)

Historic Goodwill for NovaBay Pharmaceuticals (NBY) over the last 3 years, with Q3 2023 value amounting to $348000.0.

  • NovaBay Pharmaceuticals' Goodwill fell 9231.45% to $348000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $348000.0, marking a year-over-year decrease of 9231.45%. This contributed to the annual value of $348000.0 for FY2022, which is 9231.45% down from last year.
  • NovaBay Pharmaceuticals' Goodwill amounted to $348000.0 in Q3 2023, which was down 9231.45% from $348000.0 recorded in Q2 2023.
  • Over the past 5 years, NovaBay Pharmaceuticals' Goodwill peaked at $4.5 million during Q4 2021, and registered a low of $348000.0 during Q4 2022.
  • In the last 3 years, NovaBay Pharmaceuticals' Goodwill had a median value of $2.4 million in 2021 and averaged $2.4 million.
  • Examining YoY changes over the last 5 years, NovaBay Pharmaceuticals' Goodwill showed a top increase of 9231.45% in 2022 and a maximum decrease of 9231.45% in 2022.
  • Over the past 3 years, NovaBay Pharmaceuticals' Goodwill (Quarter) stood at $4.5 million in 2021, then crashed by 92.31% to $348000.0 in 2022, then changed by 0.0% to $348000.0 in 2023.
  • Its Goodwill stands at $348000.0 for Q3 2023, versus $348000.0 for Q2 2023 and $348000.0 for Q1 2023.